| Basics |
|
89bio, Inc. Common Stock
|
| IPO Date: |
November 19, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$2.2B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.37 | 3.35%
|
| Avg Daily Range (30 D): |
$0.05 | 0.52%
|
| Avg Daily Range (90 D): |
$0.15 | 1.58%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.98M |
| Avg Daily Volume (30 D): |
6.74M |
| Avg Daily Volume (90 D): |
3.11M |
| Trade Size |
| Avg Trade Size (Sh.): |
108 |
| Avg Trade Size (Sh.) (30 D): |
352 |
| Avg Trade Size (Sh.) (90 D): |
186 |
| Institutional Trades |
| Total Inst.Trades: |
1,672 |
| Avg Inst. Trade: |
$2.36M |
| Avg Inst. Trade (30 D): |
$3.23M |
| Avg Inst. Trade (90 D): |
$3.06M |
| Avg Inst. Trade Volume: |
.2M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.54M |
| Avg Closing Trade (30 D): |
$4.94M |
| Avg Closing Trade (90 D): |
$3.04M |
| Avg Closing Volume: |
224.08K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
|
$-.71
|
$-.49
|
|
Diluted EPS
|
|
$-.71
|
$-.49
|
|
Revenue
|
$
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$
|
$ -111.5M
|
$ -71.28M
|
|
Operating Income / Loss
|
$
|
$ -115.82M
|
$ -75.91M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$
|
$ -186.32M
|
$ 189.34M
|
|
PE Ratio
|
|
|
|
|
|
|
